As part of a new deal with the Biomedical Advanced Research and Development Authority, Johnson & Johnson is investing $1bn in COVID-19 vaccine research and development

Anglo-Swiss pharmaceutical firm AstraZeneca is pushing further into the oncology market by partnering with Japanese cancer drugmaker Daiichi Sankyo

Only five percent of candidate drugs currently make it through the initial R&D phase. With demand for novel biopharmaceuticals growing, Batavia Biosciences is helping organisations improve their development processes

The cancer-treating drug was discovered and developed entirely on Chinese soil, a first for the country’s pharmaceutical sector

Irish pharmaceutical company Shire has finally accepted a takeover offer from Japan’s Takeda, bringing an end to a saga that has seen four previous bids rejected by the Dublin-based drug maker

Swiss pharmaceutical company Novartis has sought to build on its leading position in the gene therapy market with the purchase of AveXis – its second major gene therapy deal this year

French healthcare group Sanofi witnessed a sharp fall in its share price after acquiring biotech company Bioverativ for a premium, but maintains the deal will add to its earnings per share in the current financial year

The China Food and Drink Administration will review a new drug developed by Chi-Med as possible cancer treatment

Scientific instruments maker Thermo Fisher has acquired a Dutch drug company in new push towards biopharma manufacturing

The discovery of stress granules and their role in neurodegenerative disease has opened up new possibilities for the treatment of ALS and Alzheimer’s disease, according to Aquinnah Pharmaceuticals

Japan’s biggest pharmaceutical company sets its sights on foreign takeovers as it looks to bolster its position in the global drugs market

Drug developer ImmuPharma successfully raises £8.4m to fund final trial of breakthrough lupus treatment